Tadokoro Tomoko, Oura Kyoko, Nakahara Mai, Fujita Koji, Tani Joji, Morishita Asahiro, Kobara Hideki
Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, Kita-gun 761-0793, Kagawa, Japan.
Int J Mol Sci. 2025 Aug 28;26(17):8328. doi: 10.3390/ijms26178328.
Alcohol-associated liver disease (ALD) is a major cause of liver-related mortality worldwide; however, only a subset of heavy drinkers develop progressive disease, suggesting a role for host genetics. In East Asian populations, functional polymorphisms in alcohol-metabolizing enzymes, such as alcohol dehydrogenase 1B (ADH1B) and aldehyde dehydrogenase 2 (ALDH2), are common and significantly affect acetaldehyde metabolism. ADH1B accelerates ethanol oxidation, whereas ALDH2 impairs acetaldehyde detoxification and increases oxidative stress, inflammation, and liver injury. Based on genotype combinations, individuals were stratified into five alcohol sensitivity groups with differing risks of cirrhosis and cancer. Although ALDH2 deficiency often suppresses alcohol intake via aversive reactions, paradoxically, continued drinking increases the risk of liver and gastrointestinal cancers. Genetic risk stratification may inform personalized prevention and precision of public health approaches. However, expansion of direct-to-consumer genetic testing has raised ethical and educational challenges. Understanding the interaction between alcohol metabolism and genetic variations is crucial for identifying high-risk individuals and guiding tailored interventions in East Asian populations.
酒精性肝病(ALD)是全球肝脏相关死亡的主要原因;然而,只有一部分酗酒者会发展为进行性疾病,这表明宿主基因起到了一定作用。在东亚人群中,酒精代谢酶的功能性多态性,如乙醇脱氢酶1B(ADH1B)和乙醛脱氢酶2(ALDH2)很常见,并且会显著影响乙醛代谢。ADH1B加速乙醇氧化,而ALDH2则会损害乙醛解毒并增加氧化应激、炎症和肝损伤。根据基因型组合,个体被分为五个酒精敏感性组,患肝硬化和癌症的风险各不相同。虽然ALDH2缺乏通常会通过厌恶反应抑制酒精摄入,但矛盾的是,持续饮酒会增加患肝癌和胃肠道癌的风险。遗传风险分层可为个性化预防和公共卫生方法的精准化提供依据。然而,直接面向消费者的基因检测的扩展带来了伦理和教育方面的挑战。了解酒精代谢与基因变异之间的相互作用对于识别高危个体并指导东亚人群的针对性干预至关重要。